QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
ASX:ANP

Antisense Therapeutics (ANP) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)
Free ANP Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.32 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
4.58%
Price Target
N/A
Stock Analysis
Stock Analysis
ANP stock logo

About Antisense Therapeutics Stock (ASX:ANP)

Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Its product pipeline comprises ATL1102, an antisense inhibitor of CD49d, which is in Phase IIa clinical trial for the treatment of multiple sclerosis, Duchenne Muscular Dystrophy, asthma, and other inflammatory indications. The company's product pipeline also includes ATL1103, a second generation antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin-like growth factor-I in the blood, as well as to treat diseases associated with excessive growth hormone action that has completed Phase II clinical trial. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia.

ANP Stock News Headlines

April 15, 2024 | finance.yahoo.com
Anpario plc's (LON:ANP) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
April 5, 2024 | msn.com
ScoPo’s (actually Wilkie’s) Powerplays: Blinklab soars 32.5% in first healthcare IPO of 2024
April 19, 2024 | Altimetry (Ad)
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
April 1, 2024 | msn.com
ANP improves net income to MAD 105 mln in 2023
April 1, 2024 | msn.com
ANP slams Qaiser's advice to snap ties with govt
March 31, 2024 | ca.news.yahoo.com
Dutch nightclub hostage drama ends peacefully with arrest of suspect
March 31, 2024 | msn.com
Dutch nightclub hostage drama ends peacefully
March 20, 2024 | reuters.com
Dutch court finds KLM ads were misleading in 'greenwashing' suit -ANP
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 6, 2024 | msn.com
ANP calls for judicial commission to probe rigging in Feb 8 polls
March 1, 2024 | msn.com
JUI-F, ANP shun elections of top offices
February 29, 2024 | msn.com
Won't participate in election to posts of president, PM, speaker: ANP chief
February 13, 2024 | msn.com
ANP's Aimal Wali rejects polls results
January 22, 2024 | finance.yahoo.com
We Think Antisense Therapeutics (ASX:ANP) Needs To Drive Business Growth Carefully
January 15, 2024 | msn.com
ECP allocates 'lantern' symbol to ANP
January 13, 2024 | msn.com
ANP withdraws from NA-242 in favour of Shehbaz Sharif
January 13, 2024 | msn.com
Election 2024 ECP allots election symbols to ANP
December 18, 2023 | finance.yahoo.com
Some Confidence Is Lacking In Anpario plc's (LON:ANP) P/E
November 25, 2023 | msn.com
MQM-P, ANP join forces for polls
September 27, 2023 | reuters.com
Dutch court rules Chemours liable for environmental damage caused by PFAS - ANP
July 22, 2023 | msn.com
Dozens of ANP leaders in KP join Peoples Party
July 7, 2023 | yahoo.com
Dutch government to resign over asylum policy -ANP
July 7, 2023 | msn.com
Dutch government to resign over asylum policy, ANP reports
June 29, 2023 | reuters.com
Netherlands talking to three suppliers to build new nuclear power plants - ANP
June 17, 2023 | finance.yahoo.com
Here's Why We're Not Too Worried About Antisense Therapeutics' (ASX:ANP) Cash Burn Situation
May 17, 2023 | morningstar.com
Kymera Therapeutics Inc Ordinary Shares
May 10, 2023 | marketwatch.com
Antisense & RNAi Therapeutics Market 2023-2030 Study for Research by Industry Key Factors and Key Players
See More Headlines
Receive ANP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antisense Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2019
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:ANP
CUSIP
N/A
CIK
N/A
Web
www.antisense.com.au
Phone
61 3 9827 8999
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-11,380,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-73.14%
Return on Assets
-41.69%

Debt

Debt-to-Equity Ratio
1.42
Current Ratio
4.51
Quick Ratio
18.16

Sales & Book Value

Annual Sales
$1.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
4.18
Book Value
A$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
901,550,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.06
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

ANP Stock Analysis - Frequently Asked Questions

How were Antisense Therapeutics' earnings last quarter?

Antisense Therapeutics Limited (ASX:ANP) posted its earnings results on Wednesday, February, 27th. The company reported $0.00 earnings per share for the quarter.

What other stocks do shareholders of Antisense Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Antisense Therapeutics investors own include Tocagen (TOCA), Miragen Therapeutics (MGEN), Iovance Biotherapeutics (IOVA), Genocea Biosciences (GNCA), Capricor Therapeutics (CAPR) and Applied DNA Sciences (APDN).

This page (ASX:ANP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Fed launches fourth dollar overhaul
Stansberry Research